 |
|
|
|
|
|
|
|
|
|
|
 |
|
|||||||||
 |
 |
 |
 |
 |
 |
 |
 |
|
||
 |
 |
 |
|
|||||||
 |
|
|||||||||
 |
|
|||||||||
Alert Number 28
Date: June 25, 2024
We are finally at liberty to disclose the nature of the mystery monoclonal that will be used as the pivotal drug in Project Alpha. It is called "Avastin" and is made by Genentech, the same folks that have bought us Rituxan. The second part of the equation is our favorite EGCG, green tea extract. I could have told you all this many months ago, but then I would have had to kill you. This way is better, don't you agree?
We have also finally heard from our favorite governmental agency, the IRS, on our tax-exempt status. You can read about this breaking news and other details of Project Alpha on our website in Project Alpha Milestones.
Be well,
Chaya
_____
NOTICE: This page from the Topics Alert archive was originally emailed to subscribers of Topics Alert, a free service of CLL Topics Inc. If you are not a subscriber and you wish to receive email Alerts, please register at the Topics Alert subscription page. The content of this page is intended for information only and it is NOT meant to be medical advice. Please be sure to consult and follow the advice of your doctors on all medical matters.
———
Disclaimer: The content of this website is intended for information only and is NOT meant to be medical advice. Please be sure to consult and follow the advice of your doctors on all medical matters.
Copyright Notice:
Copyright © 2024-2007 CLL Topics, Inc. All Rights Reserved.
All materials contained on this site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of CLL Topics, Inc. You may not alter or remove any trademark, copyright or other notice from copies of the content.
However, you may download and print material from CLLTopics.org exclusively for your personal, noncommercial use.
———
